Literature DB >> 14171066

ANTIBACTERIAL ACTIVITY OF LINCOMYCIN AND PRISTINAMYCIN: A COMPARISON WITH ERYTHROMYCIN.

M BARBER, P M WATERWORTH.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS; BACILLUS ANTHRACIS; BACTERIOLOGICAL TECHNICS; CARCINOID TUMOR; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; NEISSERIA; SALMONELLA; SHIGELLA; STAPHYLOCOCCUS; STREPTOCOCCUS

Mesh：

Substances：

Year:  1964        PMID： 14171066      PMCID： PMC1816630          DOI： 10.1136/bmj.2.5409.603

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  Action mechanism of mikamycins. I. Effects of mikamycins on protein and nucleic acid metabolisms.

Authors:  H YAMAGUCHI
Journal:  J Antibiot (Tokyo)       Date:  1961-11       Impact factor: 2.649

2.  The antibacterial properties of leucomycin.

Authors:  P M WATERWORTH
Journal:  Antibiot Chemother (Northfield)       Date:  1960-02

3.  The erythromycin group of antibiotics.

Authors:  L P GARROD
Journal:  Br Med J       Date:  1957-07-13

4.  Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin.

Authors:  M FINLAND; W F JONES; R L NICHOLS
Journal:  Proc Soc Exp Biol Med       Date:  1956-11
  4 in total
  15 in total

Review 1.  Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.

Authors:  C Cocito
Journal:  Microbiol Rev       Date:  1979-06

2.  LINCOMYCIN HYDROCHLORIDE: CLINICAL AND LABORATORY STUDIES.

Authors:  A M GEDDES; R A SLEET; J M MURDOCH
Journal:  Br Med J       Date:  1964-09-12

3.  Use of pristinamycin for infections by gram-positive bacteria: clinical experience at an Australian hospital.

Authors:  A B Reid; J R Daffy; P Stanley; K L Buising
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

4.  Group A Streptococcus resistant to erythromycin and lincomycin.

Authors:  J M Dixon
Journal:  Can Med Assoc J       Date:  1968-12-07       Impact factor: 8.262

5.  Antibiotic inhibitors of the bacterial ribosome.

Authors:  B Weisblum; J Davies
Journal:  Bacteriol Rev       Date:  1968-12

6.  In vitro development of resistance to erythromycin, other macrolide antibiotics, and lincomycin in Mycoplasma pneumoniae.

Authors:  Y Nitu; S Hasegawa; H Kubota
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

7.  [The phenomenom of resistance and cross resistance to erythromycin, lincomycin and staphylomycin].

Authors:  S F Goldmann; F Heiss
Journal:  Z Med Mikrobiol Immunol       Date:  1971

8.  Group A streptococci resistant to lincomycin.

Authors:  J Kohn; J H Hewitt; C A Fraser
Journal:  Br Med J       Date:  1968-03-16

Review 9.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1965-09       Impact factor: 2.401

10.  Chelocardin-inducible resistance in Escherichia coli bearing R plasmids.

Authors:  Y A Chabbert; M R Scavizzi
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.